What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.84%
Annual Rate
CNY 0.40Paid annual
Payout Ratio
145.4%High
Last Ex-Dividend
Jun 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.24BCNY
1.38B · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
80.16x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Revenue (TTM)
1.03BCNY
154.06M · vs all stocks (USD)
Updated Sep 22, 2026
Profit Margin
10.37%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Beta
0.8550x
vs all stocks
Updated Sep 22, 2026
52-Week Change
25.96%
vs all stocks
Updated Sep 22, 2026
Market Capitalization
9.24BCNY
1.38B · vs all stocks (USD)
Updated Sep 22, 2026
Enterprise Value
7.14BCNY
1.07B · vs all stocks (USD)
Updated Sep 22, 2026
Trailing P/E
80.16x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Forward P/E
40.45x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Price to Sales (TTM)
8.28x
vs Scientific & Technical Instruments peers
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 8.95×.Updated Sep 22, 2026
Price to Book (MRQ)
2.80x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Enterprise to Revenue
6.92x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Enterprise to EBITDA
44.87x
vs Scientific & Technical Instruments peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 36.82×.Updated Sep 22, 2026
Gross Margin
51.51%
vs Scientific & Technical Instruments peers
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 53.97%.Updated Sep 22, 2026
Profit Margin
10.37%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Operating Margin
3.64%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Return on Assets (TTM)
1.64%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Return on Equity (TTM)
3.44%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Revenue (TTM)
1.03BCNY
154.06M · vs all stocks (USD)
Updated Sep 22, 2026
Revenue per Share (TTM)
5.37CNYUpdated Sep 22, 2026
Quarterly Revenue Growth
36.40%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Gross Profit (TTM)
557.06MCNY
83.15M · vs all stocks (USD)
Updated Sep 22, 2026
EBITDA (TTM)
193.87MCNY
28.94M · vs all stocks (USD)
Updated Sep 22, 2026
Net Income (TTM)
107.02MCNY
15.97M · vs all stocks (USD)
Updated Sep 22, 2026
Quarterly Earnings Growth (YoY)
12.60%
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Operating Cash Flow (TTM)
96.45MCNY
14.40M · vs all stocks (USD)
Updated Sep 22, 2026
Levered Free Cash Flow (TTM)
-51.50MCNY
-7.69M · vs all stocks (USD)
Updated Sep 22, 2026
Trailing Annual Dividend Rate
0.4000CNYUpdated Sep 22, 2026
Trailing Annual Dividend Yield
0.84%
vs all stocks
Updated Sep 22, 2026
Payout Ratio
145.45%
vs Scientific & Technical Instruments peers
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 72.73%.Updated Sep 22, 2026
Revenue
900.23MCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
404.38MCNYFY2025 · Dec 31, 2025
Gross Profit
495.85MCNYFY2025 · Dec 31, 2025
Operating Income
54.51MCNY
8.14M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
91.05MCNYFY2025 · Dec 31, 2025
Income Tax Expense
4.97MCNYFY2025 · Dec 31, 2025
Net Income
86.08MCNYFY2025 · Dec 31, 2025
EBIT
99.80MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
194.12MCNYFY2025 · Dec 31, 2025
Research & Development
225.89MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
220.71MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
11.29MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
3.12MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
8.75MCNYFY2025 · Dec 31, 2025
Net Income from Continuing Operations
86.08MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
16.95MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-43.85MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
344.31MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
86.08MCNYFY2025 · Dec 31, 2025
Stock-based Compensation
5.71MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
20.80MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-28.54MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-67.11MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-60.80MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-695.99MCNYFY2025 · Dec 31, 2025
Sale of Investments
1.02BCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
267.76MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
202.40MCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-500.58MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-84.71MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-49.11MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-432.00MCNYFY2025 · Dec 31, 2025
Shares Outstanding
193.87MSharesUpdated Sep 22, 2026
Float Shares
84.04MSharesUpdated Sep 22, 2026
% Held by Insiders
63.69%
vs all stocks
Updated Sep 22, 2026
% Held by Institutions
6.34%
vs all stocks
Updated Sep 22, 2026
Total Cash (MRQ)
1.63BCNY
243.33M · vs all stocks (USD)
Updated Sep 22, 2026
Total Cash per Share (MRQ)
8.23CNYUpdated Sep 22, 2026
Total Debt (MRQ)
34.74MCNY
5.19M · vs all stocks (USD)
Updated Sep 22, 2026
Total Debt to Equity (MRQ)
0.0112x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Current Ratio (MRQ)
6.82x
vs Scientific & Technical Instruments peers
Updated Sep 22, 2026
Book Value per Share (MRQ)
15.73CNYUpdated Sep 22, 2026
Total Assets
3.58BCNY
535.07M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.40BCNYFY2025 · Dec 31, 2025
Total Liabilities
423.77MCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.18BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
53.88MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
369.88MCNYFY2025 · Dec 31, 2025
Cash
313.99MCNYFY2025 · Dec 31, 2025
Cash Equivalents
38.48MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
352.47MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
1.49BCNYFY2025 · Dec 31, 2025
Accounts Receivable
194.27MCNYFY2025 · Dec 31, 2025
Inventory
326.73MCNYFY2025 · Dec 31, 2025
Accounts Payable
108.78MCNYFY2025 · Dec 31, 2025
Short-term Debt
72.93MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
258.29KCNYFY2025 · Dec 31, 2025
Long-term Debt
17.09MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
7.04MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
193.87MCNYFY2025 · Dec 31, 2025
Retained Earnings
107.91MCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
3.16BCNY
471.82M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
40.54MCNYFY2025 · Dec 31, 2025
52-Week Low
35.31CNYUpdated Sep 22, 2026
52-Week High
81.80CNYUpdated Sep 22, 2026
52-Week Change
25.96%
vs all stocks
Updated Sep 22, 2026
Beta
0.8550x
vs all stocks
Updated Sep 22, 2026
50-Day MA
42.74CNYUpdated Sep 22, 2026
200-Day MA
49.23CNYUpdated Sep 22, 2026
Avg 10-Day Volume
2.71MSharesUpdated Sep 22, 2026
Avg 30-Day Volume
3.47MSharesUpdated Sep 22, 2026
Diluted EPS (TTM)
0.5500CNYUpdated Sep 22, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Cash on hand covers most or all of its debt, and its equity share of assets is high for its industry.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 6.82×, higher than 95% of its Scientific & Technical Instruments peers (median 2.92×)Significant
Current ratio: 6.82Industry median: 2.92Industry P95: 6.30Peers compared: 34.00
Debt-to-equity is 0.01×, lower than 95% of its Scientific & Technical Instruments peers (median 0.1×)Notable